NewAmsterdam Pharma Company N.V.
$19.83
-0.79 (-3.83%)
Price as of Oct 16, 2026 market close
Performance
- 1 Month
- -9.6%
Price return, based on split- and dividend-adjusted closing prices.
Risk
- Largest decline max drawdown, since Aug 2026
- -30.5%
Own NAMS?
See how NAMS contributes to your portfolio's return, allocation, and risk.
7-day free trial, then $9/month.